Cerebral vasculitis associated with cocaine abuse or subarachnoid hemorrhage? [letter]. JAMA 1988;259:1648-9.

Krendel DA, Ditter SM, Frankel MR, Ross WK. Biopsy-proven cerebral vasculitis associated with cocaine abuse. Neurology 1990;40:1092-4.

Enriquez R, Palacios FO, Gonzalez CM, Amoros FA, Cabezuelo JB, Hernandez F. Skin vasculitis, hypokalemia and acute renal failure in rhabdomyolysis associated with cocaine [letter]. Nephron 1991;59:336-7.

Daras M, Tuchman AJ, Koppel BS, Samkoff LM, Weitzner I, Marc J. Neurovascular complications of cocaine. Acta Neurol Scand 1994;90:124-9. Barinaga M. Miami vice metabolite [news]. Science 1990;250:758.

Hearn WL, Flynn DD, Hime GW, Rose S, Cofino JC, Mantero-Atienza E, Wetli CV, Mash DC. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 1991;56:698-701.

Jatlow P, Hearn WL, Elsworth JD, Roth RH, Bradberry CW, Taylor JR. Cocaethylene inhibits uptake of dopamine and can reach high plasma concentrations following combined cocaine and ethanol use. NIDA Res Monogr 1991;105:572-3.

Hearn WL, Rose S, Wagner J, Ciarleglio A, Mash DC. Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol Biochem Behav 1991;39:531-3. Perez-Reyes M, Jeffcoat AR. Ethanol/cocaine interaction: cocaine and cocaethylene plasma concentrations and their relationship to subjective and cardiovascular effects. Life Sci 1992;51:553- 63.

Perez-Reyes M. Subjective and cardiovascular effects of cocaethylene in humans. Psychopharma-cology (Berl) 1993;113:144-7.

Covert RF, Schreiber MD, Tebbett IR, Torgerson LJ. Hemodynamic and cerebral blood flow effects of cocaine, cocaethylene and benzoylecgonine in conscious and anesthetized fetal lambs. J Pharmacol Exp Ther 1994;270:118-26.

Wilson LD, Henning RJ, Suttheimer C, Lavins E, Balraj E, Earl S. Cocaethylene causes dose-dependent reductions in cardiac function in anesthetized dogs. J Cardiovasc Pharmacol 1995;26:965-73.

Randall T. Cocaine, alcohol mix in body to form even longer lasting, more lethal drug [news]. JAMA 1992;267:1043-4.

Xu YQ, Crumb WJ, Jr., Clarkson CW. Cocaethylene, a metabolite of cocaine and ethanol, is a potent blocker of cardiac sodium channels. J Pharmacol Exp Ther 1994;271:319-25. Klein LM, Lavker RM, Matis WL, Murphy GF. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc Natl Acad Sci USA 1989;86:8972-6. Moliterno DJ, Willard JE, Lange RA, Negus BH, Boehrer JD, Glamann DB, Landau C, Rossen JD, Winniford MD, Hillis LD. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994;330:454-9.

Milroy CM, Clark JC, Forrest AR. Pathology of deaths associated with "ecstasy" and "eve" misuse. J Clin Pathol 1996;49:149-53.

Steele TD, McCann UD, Ricaurte GA. 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. Addiction 1994;89:539-51. Bashour TT. Acute myocardial infarction resulting from amphetamine abuse: a spasm- thrombus interplay? Am Heart J 1994;128:1237-9.

Ragland AS, Ismail Y, Arsura EL. Myocardial infarction after amphetamine use. Am Heart J 1993;125:247-9.

Woodrow G, Harnden P, Turney JH. Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy'). Nephrol Dial Transplant 1995;10:399-400.

King J, Richards M, Tress B. Cerebral arteritis associated with heroin abuse. Med J Aust 1978;2:444-5.

Citron BP, Halpern M, McCarron M, Lundberg GD, McCormick R, Pincus IJ, Tatter D, Haverback BJ. Necrotizing angiitis associated with drug abuse. N Engl J Med 1970;283:1003-11.

de Araujo MS, Gerard F, Chossegros P, Porto LC, Barlet P, Grimaud JA. Vascular hepatotox-icity related to heroin addiction. Virchows Arch A Pathol Anat Histopathol 1990;417:497-503. Bakir AA, Dunea G. Drugs of abuse and renal disease. Curr Opin NephrolHypertens 1996;5:122-6.

Murphy DA, O'Blenes S, Nassar BA, Armour JA. Effects of acutely raising intracranial pressure on cardiac sympathetic efferent neuron function. Cardiovasc Res 1995;30:716-24. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Del Bo A, Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994;90:248-53.

Pitillo R, Cigarette smoking and endothelial injuy: A review. Tobacco Smoking and Atherosclerosis. 1989, New York: Plenum Press.

84. Wright SC, Zhong J, Zheng H, Larrick JW. Nicotine inhibition of apoptosis suggests a role in tumor promotion. Faseb J 1993;7:1045-51.

85. Totti Nd, McCusker KT, Campbell EJ, Griffin GL, Senior RM. Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. Science 1984;223:169-71.

86. Lagrue G, Verra F, Lebargy F. Nicotine patches and vascular risks [letter; comment]. Lancet 1993;342:564.

87. Van der Klauw MM, Van Hillo B, Van den Berg WH, Bolsius EP, Sutorius FF, Stricker BH. Vasculitis attributed to the nicotine patch (Nicotinell). Br J Dermatol 1996;134:361-4.

88. Steffee CH, Davis GJ, Nicol KK. A whiff of death: fatal volatile solvent inhalation abuse. South Med J 1996;89:879-84.

89. Cunningham SR, Dalzell GW, McGirr P, Khan MM. Myocardial infarction and primary ventricular fibrillation after glue sniffing. Br Med J (Clin Res Ed) 1987;294:739-40.

90. McLeod AA, Marjot R, Monaghan MJ, Hugh-Jones P, Jackson G, Timmis AD, Smyth P, Monaghan M, Walker L, Daly K, McLeod AA, Jewitt DE. Chronic cardiac toxicity after inhalation of 1,1,1-trichloroethane Milrinone in heart failure. Acute effects on left ventricular systolic function and myocardial metabolism. Br Med J (Clin Res Ed) 1987;294:727-9.

91. Warrington SJ, Padgham C, Lader M. The cardiovascular effects of antidepressants. Psychol Med Monogr Suppl 1989;16:i-iii, 1-40.

92. Glassman AH, Preud'homme XA. Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry 1993;54 Suppl:16-22.

93. Chamsi-Pasha H, Barnes PC. Myocardial infarction: a complication of amitriptyline overdose. Postgrad Med J 1988;64:968-70.

94. Magee R. Saint Anthony's fire revisited. Vascular problems associated with migraine medication. Med J Aust 1991;154:145-9.

95. Weaver R, Phillips M, Vacek JL. St. Anthony's fire: a medieval disease in modern times: case history. Angiology 1989;40:929-32.

96. Iffy L, McArdle JJ, Ganesh V, Hopp L. Bromocriptine related atypical vascular accidents postpartum identified through medicolegal reviews. Med Law 1996;15:127-34.

97. McKiernan TL, Bock K, Leya F, Grassman E, Lewis B, Johnson SA, Scanlon PJ. Ergot induced peripheral vascular insufficiency, non-interventional treatment. Cathet Cardiovasc Diagn 1994;31:211-4.

98. Raroque HG, Jr., Tesfa G, Purdy P. Postpartum cerebral angiopathy. Is there a role for sympathomimetic drugs? Stroke 1993;24:2108-10.

99. Pietrogrande F, Caenazzo A, Dazzi F, Polato G, Girolami A. A role for platelet-derived growth factor in drug-induced chronic ergotism? A case report. Angiology 1995;46:633-6.

100. Oliver JW, Abney LK, Strickland JR, Linnabary RD. Vasoconstriction in bovine vasculature induced by the tall fescue alkaloid lysergamide. J Anim Sci 1993;71:2708-13.

101. Skop BP, Finkelstein JA, Mareth TR, Magoon MR, Brown TM. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease [see comments]. Am J Emerg Med 1994;12:642-4.

102. Wiener I, Tilkian AG, Palazzolo M. Coronary artery spasm and myocardial infarction in a patient with normal coronary arteries: temporal relationship to pseudoephedrine ingestion. Cathet Cardiovasc Diagn 1990;20:51-3.

103. Adverse events associated with ephedrine-containing products—Texas, December 1993- September 1995. MMWR Morb Mortal Wkly Rep 1996;45:689-93.

104. Li P, Tong C, Eisenach JC. Pregnancy and ephedrine increase the release ofnitric oxide in ovine uterine arteries. Anesth Analg 1996;82:288-93.

105. Wooten MR, Khangure MS, Murphy MJ. Intracerebral hemorrhage and vasculitis related to ephedrine abuse. Ann Neurol 1983;13:337-40.

106. Glick R, Hoying J, Cerullo L, Perlman S. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. Neurosurgery 1987;20:969-74.

107. Forman HP, Levin S, Stewart B, Patel M, Feinstein S. Cerebral vasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature. Pediatrics 1989;83:737-41.

108. Nadeau SE. Intracerebral hemorrhage and vasculitis related to ephedrine abuse [letter]. Ann Neurol 1984;15:114-5.

109. Sawyer DR, Conner CS, Rumack BH. Managing acute toxicity from nonprescription stimulants. Clin Pharm 1982;1:529-33.

110. Kokkinos J, Levine SR. Possible association of ischemic stroke with phentermine. Stroke 1993;24:310-3.

111. Fallis RJ, Fisher M. Cerebral vasculitis and hemorrhage associated with phenylpropanolamine. Neurology 1985;35:405-7.

112. Mayeno AN, Gleich GJ. The eosinophilia-myalgia syndrome: lessons from Germany [editorial; comment]. Mayo Clin Proc 1994;69:702-4.

113. Tabuenca JM. Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 1981;2:567-8.

114. Carr L, Ruther E, Berg PA, Lehnert H. Eosinophilia-myalgia syndrome in Germany: an epidemiologic review [see comments]. Mayo Clin Proc 1994;69:620-5.

115. Campagna AC, Blanc PD, Criswell LA, Clarke D, Sack KE, Gold WM, Golden JA. Pulmonary manifestations of the eosinophilia-myalgia syndrome associated with tryptophan ingestion. Chest 1992;101:1274-81.

116. Hertzman PA, Maddoux GL, Sternberg EM, Heyes MP, Mefford IN, Kephart GM, Gleich GJ. Repeated coronary artery spasm in a young woman with the eosinophilia-myalgia syndrome. JAMA 1992;267:2932-4.

117. Hayashi T, James TN. Immunohistochemical analysis of lymphocytes in postmortem study of the heart from fatal cases of the eosinophilia myalgia syndrome and of the toxic oil syndrome. Am Heart J 1994;127:1298-308.

A Disquistion On The Evils Of Using Tobacco

A Disquistion On The Evils Of Using Tobacco

Among the evils which a vitiated appetite has fastened upon mankind, those that arise from the use of Tobacco hold a prominent place, and call loudly for reform. We pity the poor Chinese, who stupifies body and mind with opium, and the wretched Hindoo, who is under a similar slavery to his favorite plant, the Betel but we present the humiliating spectacle of an enlightened and christian nation, wasting annually more than twenty-five millions of dollars, and destroying the health and the lives of thousands, by a practice not at all less degrading than that of the Chinese or Hindoo.

Get My Free Ebook

Post a comment